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Purpose
Quality of life (QOL) studies in JIA-associated uveitis
(JIA-U) focus on the ocular exam and global measures
of QOL. However, these assessments may not accurately
measure the impact of visual impairment (VI) on a
child’s daily activities. Hence, a child-centered approach
is crucial in this assessment. We report on the validity
and reliability of a new self-report tool to measure
vision related QOL (VRQOL) in children 8-18 years of
age, “Effects of Youngsters’ Eyesight on QOL (EYE-Q)”.
Methods
We recruited 120 children, 8-18 years of age, in a pediatric
eye clinic. Best corrected visual acuity (VA) was measured
using the Snellen chart. Patient-based questionnaires were
administered– EYE-Q to measure VRQOL, and Pediatric
Quality of Life Inventory (PedsQL) to determine overall
QOL. Patients rated their eyesight as excellent (1), good
(2), fair (3), poor (4), very poor (5) or completely blind (6).
Parents and physicians assessed vision severity and scored
how much the child’s life was affected by their vision from
1-10 (1 - vision does not affect function in daily activities,
and 10 - vision affects function in daily activities).
Results
Of 120 children, 48% were female, 61% were white, 46.7%
had normal vision (both eyes with VA better than 20/40),
54.4% had VI (any eye with VA of 20/40 or worse) and
20.8% required the use of at least one visual aid. Mean
age was 11.3 (SD 2.7). Mean scores of the measures in
children with VI are shown in Table 1.
Patient vision assessment had a moderate association
with EYE-Q (0.489); mild associations with VI (r = 0.266),
VA (r = 0.340), physician vision assessment (r = 0.315),
and need for visual aids (r = -0.281); and no association
with PedsQL, laterality of VI, and parent vision assessment
(Table 2). Parent vision assessment had mild associations
with VI (r = 0.280), VA (r = 0.239), EYE-Q (r = -0.297),
need for aids (r = -0.281), and physician assessment (r =
0.384); and no association with Peds QL and laterality of
VI. Patient vision assessment had stronger associations
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Eye-Q1 (range of scores 0-4)+ 3.22 (0.74)
PedsQL2 Total (0-100)+ 76.0 (16.5)
Patient vision assessment (1-6)++ 2.3 (1.2)
Patient vision assessment (1-10)++ 5.6 (2.9)
Physician vision assessment (1-10)++ 4.0 (2.5)
§ Vision impairment – any eye with a VA of 20/40 or worse
1Effects of youngsters’ eyesight on QOL; 2Pediatric quality of life inventory
score
+Higher scores indicate better quality of life, ++Higher values indicate worse
vision severity
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with the EYE-Q and VA compared to parent vision
assessment.
Conclusion
VI can have a significant impact on the VRQOL of chil-
dren with ocular disease. Our study demonstrates that
child-reported VRQOL and vision assessment has good
validity but can differ from the parent’s assessment. Both
parent and child reports may have valid contributions in
the assessment of VRQOL and visual outcome. Hence, the
child’s perspective should be included in QOL studies in
JIA-U. A vision-specific self-report instrument like the
EYE-Q may be an important tool in the assessment of
VRQOL in JIA-U, may complement current measures of
VI, and may be more valid than measures of overall QOL
alone.
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Table 2 Correlations (r) between patient and parent vision assessments and measures of vision impairment§
Patient vision assessment (1-6)+++ P value Parent vision assessment (1-10)+++ P value
Vision impairment§ 0.266 0.003** 0.280 0.002**
Eye-Q1 (range of scores 0-4)+ -0.489 <0.001* -0.297 0.001**
PedsQL2 Total (0-100)+ -0.064 0.488 -0.053 0.569
Logmar far VA3, better eye (-0.30-3.00)++ 0.340 <0.001* 0.239 0.009**
Need for visual aids -0.281 0.002** -0.281 0.002**
Laterality of disease 0.108 0.238 0.143 0.121
Patient vision assessment (1-10)+++ 0.166 0.072
Physician vision assessment (1-10)+++ 0.315 <0.001* 0.384 <0.001*
1Effects of youngsters’ eyesight on QOL; 2Pediatric quality of life inventory; 3Visual acuity
*<0.001, **<0.05 using person’s coefficient
§ Vision impairment – any eye with a VA of 20/40 or worse
++Lower values indicate better vision and VA
+++Higher values indicate worse vision severity
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